一个有效的瘤抑制siRNA输送平台.
1Department of Pathology, University of Maryland School of Medicine, University of Maryland Baltimore, 10 S. Pine St., Baltimore, MD, 21201, USA.
Biochemical and biophysical research communications
|February 15, 2026
概括
这项研究表明,海斯蒂丁-氨酸 (HK) 多复合物有效地将siRNA传递给三阴性乳腺癌细胞. 该系统通过准Raf-1和PD-L1瘤基因,显著减少了瘤的大小.
科学领域:
- 生物技术是生物技术.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 希斯蒂丁-氨酸 (HK) 可以输送siRNA,准瘤特异性受体,如神经素-1 (NRP-1).
- 在侵略性瘤中,包括三阴性乳腺癌 (TNBC) 中,NRP-1 过度表达.
研究的目的:
- 评估HK-siRNA输送系统对TNBC的抗瘤疗效.
- 在体内使用该系统评估Raf-1和PD-L1瘤基因的向性.
主要方法:
- 携带siRaf-1或siPD-L1的HK多复合体的系统输送给MDA-MB-231瘤携带的无血小鼠.
- 在治疗后测量瘤大小和蛋白质水平分析 (Raf-1,PD-L1).
- 监测动物体重作为系统毒性的指标.
主要成果:
- 与siControl相比,siRaf-1和siPD-L1多复合体分别减少了75%和82%的瘤体积.
- 瘤大小的减少与减少的Raf-1和PD-L1蛋白表达相关.
- 在治疗组中没有观察到显著的体重减轻,这表明耐受性良好.
结论:
- HK多复合体是TNBC中向siRNA传递的有希望的平台.
- 该系统显示出显著的抗瘤活性,需要进一步的临床开发.
- 用siRNA针对Raf-1和PD-L1等瘤基因提供了一个可行的治疗策略.
相关概念视频
Experimental RNAi
7.8K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.8K
siRNA - Small Interfering RNAs
18.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.8K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K


